Topical GHK-CU primarily affects the skin directly
Description Reta/Cagri Blend 12.5mg/2.5mg Research-Grade Compound Reta/Cagri Blend 12.5mg/2.5mg is a research-grade compound supplied in a sterile vial, intended for use in controlled laboratory settings
For patients requiring additional therapeutic effect, the dose may be increased to 1 mg of semaglutide weekly after at least four weeks at the 0.5 mg dose
The recommended options for research are: Sterile Bacteriostatic Water (0.9% benzyl alcohol): The most common choice for multi-dose vials in rodent in vivo studies
Published preclinical studies use it as a chemical tool to investigate NNMT activity, nicotinamide metabolism, cellular methyl-donor balance, NAD-related pathways, and adipocyte biology in cell and animal models
Once absorbed, intracellular esterases remove the acetyl group to release free glutathione